The hole cut to define the field exposed only a minimally sized site to be irradiated. The rest of the face, including vulnerable OAR, were protected. The length of time during which the patient's presence was required was minimal, as was the time spent by staff to create the mask.
CONCLUSION
Using this technology to create lead shielding for radiotherapy of skin cancer of the face is an innovative and exciting approach. This could save valuable clinic time and add patient convenience. Some traditional methods require an extra appointment to create a facial mould. The optical scan can be obtained on the day of the clinical visit with no subsequent visit required until first treatment. If there are issues generating the lead shield the patient doesn't need to come in for another visit; the saved 3D optical image can be used to generate another lead shield. The cost of manufacture is also low; centres, such as those in the developing world that may not have the infrastructure to treat skin cancer with electrons could use this method to safely deliver ortho-voltage treatments. A significant number of patients suffer from claustrophobia, and this could be addressed by using this technology
